摘要
目前糖尿病已成为最常见的慢性代谢性疾病之一,而2型糖尿病患者合并慢性阻塞性肺疾病、肿瘤、血液系统疾病、肾病、皮肤病、风湿免疫病等时往往离不开糖皮质激素(glucocordicoids,GC)的治疗,但在糖尿病患者中应用GC可能会加重糖尿病病情,使血糖控制恶化甚至导致严重并发症,导致糖皮质激素在2型糖尿病患者中应用难度增大,目前对此类患者的管理主要基于临床医生对药理学的理解和个人经验,其血糖管理现状不容乐观。
At present,diabetes has become one of the most common chronic metabolic diseases,and patients with type 2 diabetes often have glucocorticoids when they are associated with chronic obstructive pulmonary disease,tumor,blood system diseases,kidney diseases,skin diseases,rheumatism and immune diseases.Treatment with glucocordicoids(GC),but the use of GC in patients with diabetes may aggravate the condition of diabetes,worsen blood glucose control and even lead to serious complications,making glucocorticoids more difficult to apply in patients with type 2 diabetes.At present,such patient management is mainly based on the understanding of pharmacology and the personal experience of clinicians,and the current status of blood glucose management is not optimistic.
作者
李娜(综述)
王彦(审校)
LI Na;WANG Yan(The First Clinical Medical College,Shanxi Medical University,Taiyuan 030000,China)
出处
《临床与病理杂志》
2020年第3期760-767,共8页
Journal of Clinical and Pathological Research
关键词
2型糖尿病
糖皮质激素
血糖管理
并发症
type 2 diabetes
glucocorticoids
glycemic management
complications
